Inventor
Christopher Andrew Gajda
Inventor
Ann Arbor, MI, US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds37%
C07CAcyclic or carbocyclic compounds16%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
PatentTitleYear
6,927,217'HIV protease inhibitors'20056,852,711'HIV protease inhibitors'20056,528,510'HIV protease inhibitors'20036,512,006'HIV protease inhibitors'20036,380,400'Methods of making dihydropyrone HIV protease inhibitors'20026,046,355'Dihydropyrones with improved antiviral activity'20005,834,506'Dihydropyrones with improved antiviral activity'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2005Patents assigned to WARNER LAMBERT CO (5)· patent assignee history
1998–2005Based in Ann Arbor, MI, US· patent location history
2005Patents assigned to AGOURON PHARMA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| WARNER LAMBERT CO | 5 | 1998–2005 |
| AGOURON PHARMA | 1 | 2005 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ann Arbor, MI, US | 7 | 1998–2005 |